Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Cambridge NeuroScience awarded sixteenth SBIR grant

Oct. 13, 1997

Roussel Uclaf develops estrogenic compounds

Oct. 9, 1997

FDA panel recommends approval of new uterine thermal ablation system

Oct. 8, 1997

Idoxifene progresses to phase III for osteoporosis

Oct. 8, 1997

Geref cleared for pediatric growth disorders in U.S.

Oct. 8, 1997

Antihyperlipidemic/antidiabetic agents reported by Otsuka

Oct. 8, 1997

Agents for postmenopausal syndrome in development at Lilly

Oct. 8, 1997

Spine-Tech and Sulzer Orthopedics Biologics announce alliance

Oct. 6, 1997

Mitsui Toatsu's hGH enters clinical testing this month

Oct. 6, 1997

Efficacy of cholesterol biosynthesis inhibitor demonstrated in dogs

Oct. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...